Pneumonia Testing Market Predicted to Witness Surge in The Near Future

Pneumonia Testing
Pneumonia Testing


Pneumonia is an infection of the lungs caused by bacteria, viruses, or fungi that primarily affects the small sir sacs known as alveoli. Streptococcus pneumoniae is the most common bacterial type that causes pneumonia. Pneumonia symptoms include fever, chills, cough, shortness of breath, and fatigue. Blood tests, chest X-rays, pulse oximetry, and sputum tests are used to determine whether a person has pneumonia. Furthermore, if the patient is over the age of 65, additional tests for pneumonia detection are included. For example, a CT scan or a pleural fluid culture.

Market Dynamics of Pneumonia Testing

Recent advancements in pneumonia testing systems, such as the development of enhanced nucleic acid detection tests and advancements in POC tests, are major factors driving the Growth of The Pneumonia Testing Market size. POC tests have a number of advantages, including ease of use and quick results. For example, the urinary antigen is a highly effective rapid test that enables targeted therapy for legionnaires at the point-of-care.

Furthermore, rising adoption of molecular diagnostic tests in developing economies is expected to provide lucrative opportunities in the market for pneumonia testing. Because of the benefits of biomarkers, such as assisting in the early detection of specific diseases, the molecular diagnostics test for Pneumonia Testing Market is expected to grow. Initially, cultures are used in the traditional method to detect pneumonia causative organisms. When compared to rapid diagnostics, this is a time-consuming process with a higher error rate. In a few cases, such as legionella, culture identification is difficult, which increases the mortality rate of legionella-caused pneumonia cases.

Regional Insights into the Pneumonia Testing Market

In 2016, North America held the largest share of the Pneumonia Testing Market, followed by Europe. This is due to the growing popularity of POC tests in the healthcare sector. Furthermore, ongoing research and development activities for the development of more advanced PCR-based technologies, which could be used for faster results, are on the rise. Furthermore, the market for pneumonia testing in Europe accounts for the second largest share, owing to a robust, well-developed healthcare infrastructure and a greater awareness of a geriatric population prone to developing such health issues.

Comments

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

Global Report on LED Driver Market for the Forecast Period 2023-2030